Revenue: The sum of all revenue fields included for a company's operating activities.
Sangamo Therapeutics, Inc. (SGMO) had Revenue of $6.44M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$6.44M |
$-30.60M |
|
-- |
|
$6.44M |
|
$36.06M |
|
$-29.63M |
|
$-0.85M |
|
$-30.48M |
|
$-30.48M |
|
$-30.60M |
|
$-30.60M |
|
$-30.60M |
|
$-30.60M |
|
$-29.63M |
|
$-27.70M |
|
220.27M |
|
220.27M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$37.60M |
|
$16.88M |
|
$48.57M |
|
$86.17M |
|
$49.56M |
|
-- |
|
$31.70M |
|
$81.26M |
|
$4.91M |
|
$4.91M |
|
$4.91M |
|
225.36M |
|
| Cash Flow Statement Financials | |
$-26.15M |
|
$0.00M |
|
$8.13M |
|
$43.42M |
|
$26.68M |
|
$-16.74M |
|
$2.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-460.28% |
|
-460.28% |
|
-- |
|
-473.48% |
|
-475.33% |
|
$-26.15M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
17.59 |
|
5.12 |
|
-623.65% |
|
-623.67% |
|
-35.51% |
|
-623.66% |
|
$0.02 |
|
$-0.12 |
|
$-0.12 |
|